[1] Gartner S, Schlossman A. Retinitis pigmentosa associated with glaucoma[J]. Am J Ophthalmol, 1949, 32(10):1337-1350. [2] Sayo A, Ueno S, Kominami T, et al. Longitudinal study of visual field changes determined by Humphrey Field Analyzer 10-2 in patients with retinitis pigmentosa[J]. Sci Rep, 2017, 7(1): 16383. [3] 田雪莲, 唐莉, 张鑫, 等. 原发性视网膜色素变性合并青光眼的临床特征[J]. 中华眼底病杂志, 2021, 37(6): 423-428. [4] Meirelles S H S, Barreto A S, Buscacio E S, et al. Retinitis pigmentosa with concomitant essential iris atrophy and glaucoma-case report[J]. Clin Ophthalmol, 2015, 9: 2139-2145. [5] Ko Y C, Liu C J, Hwang D K, et al. Increased risk of acute angle closure in retinitis pigmentosa: a population-based case-control study[J]. PLoS One, 2014, 9(9): e107660. [6] Xu J A, Ouyang Z K, Yang Y F, et al. Ocular biometry in primary angle-closure glaucoma associated with retinitis pigmentosa[J]. J Ophthalmol, 2017, 2017: 9164846. [7] Weinreb R N, Aung T, Medeiros F A. The pathophysiology and treatment of glaucoma: a review[J]. JAMA, 2014, 311(18): 1901-1911. [8] 梁之桥, 游舒棋, 张瑜, 等. 超声生物显微镜观察急性闭角型青光眼与慢性闭角型青光眼眼前节结构差异的对比研究[J]. 中华眼科杂志, 2021, 57(9): 672-678. [9] Liu X, Li M, Zhong Y M, et al. Damage patterns of retinal nerve fiber layer in acute and chronic intraocular pressure elevation in primary angle closure glaucoma[J]. Int J Ophthalmol, 2010, 3(2): 152-157. [10] Song W L, Shan L, Cheng F, et al. Prevalence of glaucoma in a rural northern China adult population: a population-based survey in Kailu county, Inner Mongolia[J]. Ophthalmology, 2011, 118(10): 1982-1988. [11] Liu L F, Liu X Y, Huang C K, et al. Associated factors of acute primary angle closure glaucoma in a sub-group of Chinese people: comparison between attack eyes and normal controls[J]. Sci Rep, 2017, 7(1): 14885. [12] Lai J S, Liu D T, Tham C C, et al. Epidemiology of acute primary angle-closure glaucoma in the Hong Kong Chinese population: prospective study[J]. Hong Kong Med J, 2001, 7(2): 118-123. [13] Liang Y B, Friedman D S, Zhou Q, et al. Prevalence and characteristics of primary angle-closure diseases in a rural adult Chinese population: the Handan Eye Study[J]. Invest Ophthalmol Vis Sci, 2011, 52(12): 8672-8679. [14] George R, Paul P G, Baskaran M, et al. Ocular biometry in occludable angles and angle closure glaucoma: a population based survey[J]. Br J Ophthalmol, 2003, 87(4): 399-402. [15] Ritch R, Chang B M, Liebmann J M. Angle closure in younger patients[J]. Ophthalmology, 2003, 110(10): 1880-1889. [16] 胡婕, 江冰. 急性和慢性原发性闭角型青光眼患者眼部生物学特征[J]. 中南大学学报(医学版), 2014, 39(4): 333-337. [17] Ghose S, Sachdev M S, Kumar H. Bilateral nanophthalmos, pigmentary retinal dystrophy, and angle closure glaucoma—a new syndrome?[J]. Br J Ophthalmol, 1985, 69(8): 624-628. [18] MacKay C J, Shek M S, Carr R E, et al. Retinal degeneration with nanophthalmos, cystic macular degeneration, and angle closure glaucoma. A new recessive syndrome[J]. Arch Ophthalmol, 1987, 105(3): 366-371. [19] Badeeb O, Trope G, Musarella M. Primary angle closure glaucoma and retinitis pigmentosa[J]. Acta Ophthalmol (Copenh), 1993, 71(6): 727-732. [20] Wang M, Lin H T, Bai Y J, et al. Clinical evidence in concurrence of retinitis pigmentosa and glaucoma[J]. Chin Med J (Engl), 2011, 124(8): 1270-1274. [21] Ten Berge J C, Fazil Z, van den Born I, et al. Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract[J]. Acta Ophthalmol, 2019, 97(2): 185-192. |